Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Using the ΔvapCO2 / Cav02 Ratio as a Prognostic Marker and Predictor of Complications After Cardiac Surgery

NCT02876406 is registered in ClinicalTrials.gov with Hospital San Carlos, Madrid as lead sponsor.

NCT NCT02876406
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02876406 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Using the ΔvapCO2 / Cav02 Ratio as a Prognostic Marker and Predictor of Complications After Cardiac Surgery
Lead sponsor
Hospital San Carlos, Madrid
Phase
Observational
Overall status
Unknown status
Start date
October 31, 2016
Completion date
October 31, 2017
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac surgery, disorder of blood gas, postoperative complications, shock